Economic impact of juvenile idiopathic arthritis and familial Mediterranean fever

Rheumatology International

Volumn 32, Issue 7, 2012, Pages 1955-1962

  Yucel, Ilker Kemal ^a   Seyahi, Emire ^a   Kasapcopur, Ozgur ^b   Arisoy, Nil ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Anti TNF agents; Cost of illness study; Direct costs; Etanercept; Familial Mediterranean fever; Indirect costs; Juvenile idiopathic arthritis; Turkey

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; COLCHICINE; CYCLOSPORIN; ETANERCEPT; IBUPROFEN; INDOMETACIN; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SALAZOSULFAPYRIDINE; VITAMIN D;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE DURATION; ENTHESOPATHY; FAMILIAL MEDITERRANEAN FEVER; FEE; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SCHOOL; ONSET AGE; OUTPATIENT DEPARTMENT; PARENT; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SCHOOL CHILD; STRUCTURED QUESTIONNAIRE; TURKEY (REPUBLIC);

EID: 84863984392     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1894-y     Document Type: Article

References (27)

1. Minden K (2006) What are the costs of childhood rheumatic disease? Best Pract Res 20:223-240
2. Minden K, Niewerth M, Listing J et al (2004) Burden and cost of illness in patients with juvenile idiopathic arthritis. Ann Rheum Dis 63:836-842 (Pubitemid 38850456)
3. Allaire SH, DeNardo BS, Ilona SS et al (1992) The economic impacts of juvenile rheumatoid arthritis. J Rheumatol 19:952-955
4. Haapasaari J, Kautiainen HJ, Isomaki HA, Hakala M (2004) Etanercept does not essentially increase the total costs of the treatment of refractory juvenile idiopathic arthritis. J Rheumatol 31:2286-2289 (Pubitemid 39453252)
5. Bernatsky S, Duffy C, Malleson P et al (2007) Economic impact of juvenile idiopathic arthritis. Arthr Rheum 57:44-48
6. Thornton J, Lunt M, Ashcroft DM et al (2008) Costing juvenile idiopathic arthritis: Examining patient based costs during the first year after diagnosis. Rheumatology 47:985-990 (Pubitemid 351865920)
7. Minden K, Niewerth M, Listing J, Möbius D, Thon A, Ganser G, Ermisch-Omran B, Zink A (2009) The economic burden of juvenile idiopathic arthritis-results from the German paediatric rheumatologic database. Clin Exp Rheumatol 27:863-869
8. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E, Turkish FMF Study Group (2005) Familial Mediterranean fever (FMF) in Turkey: Results of a nationwide multicenter study. Medicine (Baltimore) 84:1-11 (Pubitemid 40130180)
9. Ben-Chetrit E, Levy M (1998) FMF. Lancet 351:659-664
10. Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001. J Rheumatol 31:390-392 (Pubitemid 38160763)
11. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthr Rheum 40:1879-1885 (Pubitemid 27452541)
12. Ozdogan H, Ruperto N, Kasapçopur O, Bakkaloglu A, Arisoy N, Ozen S, Ugurlu U, Unsal E, Melikoglu M, Paediatric Rheumatology International Trials Organisation (2001) The Turkish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 19(4 Suppl 23):S158-S162 (Pubitemid 33730208)
13. http://www.sgk.gov.tr/wps/portal/en
14. http://en.wikipedia.org/wiki/Health-care-in-Turkey
15. http://www.euro.who.int/-data/assets/pdf-file/0007/96415/e79838. pdf
16. http://www.tuik.gov.tr
17. Huscher D, Merkesdal S, Thiele K, Zeidler H, Schneider M, Zink A, German Collaborative Arthritis Centres (2006) Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis 65:1175-1183 (Pubitemid 44277392)
18. Jacobsson LT, Lindroth Y, Marsal L, Juran E, Bergström U, Kobelt G (2007) Rheumatoid arthritis: What does it cost and what factors are driving those costs? Results of a survey in a community-derived population in Malmö, Sweden. Scand J Rheumatol 36:179-183 (Pubitemid 47174541)
19. Sut N, Seyahi E, Yurdakul S, Senocak M, Yazici H (2007) A cost analysis of Behcet's syndrome in Turkey. Rheumatology (Oxford) 46:678-682 (Pubitemid 46523316)
20. Kisacik B, Yildirim B, Tasliyurt T, Ozyurt H, Ozyurt B, Yuce S, Kaya S, Ertenli I, Kiraz S (2009) Increased frequency of familial Mediterranean fever in northern Turkey: A population-based study. Rheumatol Int 29:1307-1309
21. Seyahi E, Tahir Turanli E, Mangan MS, Celikyapi G, Oktay V, Cevirgen D, Kuzuoglu D, Ozoglu S, Yazici H (2010) The prevalence of Behçet's syndrome, familial Mediterranean fever, HLA-B51 and MEFV gene mutations among ethnic Armenians living in Istanbul, Turkey. Clin Exp Rheumatol 28(4 Suppl 60):S67-S75
22. Ellison-Loschmann L, Sunyer J, Plana E, Pearce N, Zock JP, Jarvis D, Janson C, Antó JM, Kogevinas M, European Community Respiratory Health Survey (2007) Socioeconomic status, asthma and chronic bronchitis in a large community-based study. Eur Respir J 29:897-905 (Pubitemid 46711893)
23. Falkstedt D, Lundberg I, Hemmingsson T (2010) Childhood socio-economic position and risk of coronary heart disease in middle age: A study of 49 321 male conscripts. Eur J Public Health. 4 Nov 2010. [Epub ahead of print]
24. Sule S, Petri M (2006) Socioeconomic status in systemic lupus erythematosus. Lupus 15:720-723
25. Seyahi E, Ugurlu S, Seyahi N, Celik AF, Melikoglu M, Fresko I, Hamuryudan V, Yurdakul S, Yazici H (2004) A survey of socioeconomic status in Behçet's Syndrome. Clin Exp Rheumatol 22(Suppl 34):S88
26. Lee SJ, Kavanaugh A (2004) A need for greater reporting of socioeconomic status and race in clinical trials. Ann Rheum Dis 63:1700-1701 (Pubitemid 39573710)
27. Nielsen HE, Dørup J, Herlin T, Larsen K, Nielsen S, Pedersen FK (1999) Epidemiology of juvenile chronic arthritis: Risk dependent on sibship, parental income, and housing. J Rheumatol 26:1600-1605 (Pubitemid 29317886)